EMD-386088 is an indole derivative which is used in scientific research. It acts as a potent 5-HT6 receptor partial agonist, with a Ki of 1 nM, a significantly higher affinity than older 5-HT6 agonists such as EMDT, although it possesses moderate affinity for the 5-HT3 receptor as well.[1] Subsequent research has determined that EMD-386088 is also a dopamine reuptake inhibitor and that this action is involved in the antidepressant-like effects of the drug in rodents.[2]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H14ClN2 |
Molar mass | 245.73 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
EMD-386088 can be further reacted with a butyrophenone sidechain.[3]
See also
editReferences
edit- ^ Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, et al. (October 2005). "2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists". Bioorganic & Medicinal Chemistry Letters. 15 (19): 4230–4234. doi:10.1016/j.bmcl.2005.06.067. PMID 16055331.
- ^ Jastrzębska-Więsek M, Siwek A, Partyka A, Antkiewicz-Michaluk L, Michaluk J, Romańska I, et al. (August 2016). "Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats". Naunyn-Schmiedeberg's Archives of Pharmacology. 389 (8): 839–849. doi:10.1007/s00210-016-1245-3. PMC 4939156. PMID 27106213.
- ^ Genus Possanza, Kurt Freter, & Sven Luttke, U.S. patent 3,980,658 (1976 to Boehringer Ingelheim GmbH).